Autonomous rhythmic activity in glioma networks drives brain tumour growth-Reference-Cited by-同舟云学术

Autonomous rhythmic activity in glioma networks drives brain tumour growth

Published:2022-12-14 Issue:7942 Volume:613 Page:179-186
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Hausmann David^ORCID,Hoffmann Dirk C.^ORCID,Venkataramani Varun^ORCID,Jung Erik,Horschitz Sandra,Tetzlaff Svenja K.,Jabali Ammar,Hai Ling,Kessler Tobias^ORCID,Azoŕin Daniel D.,Weil Sophie,Kourtesakis Alexandros,Sievers Philipp^ORCID,Habel Antje^ORCID,Breckwoldt Michael O.^ORCID,Karreman Matthia A.,Ratliff Miriam^ORCID,Messmer Julia M.^ORCID,Yang Yvonne,Reyhan Ekin^ORCID,Wendler Susann,Löb Cathrin,Mayer Chanté,Figarella Katherine^ORCID,Osswald Matthias,Solecki Gergely,Sahm Felix^ORCID,Garaschuk Olga,Kuner Thomas,Koch Philipp^ORCID,Schlesner Matthias^ORCID,Wick Wolfgang^ORCID,Winkler Frank^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-022-05520-4.pdf

Reference38 articles.

1. Weller, M. et al. Glioma. Nat. Rev. Dis. Primers 1, 15017 (2015).

2. Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93–98 (2015).

3. Venkataramani, V. et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573, 532–538 (2019).

4. Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539–545 (2019).

5. Gritsenko, P. G. et al. p120-catenin-dependent collective brain infiltration by glioma cell networks. Nat. Cell Biol. 22, 97–107 (2020).

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups;Computational and Structural Biotechnology Journal;2024-12

2. Recent advances in biomimetic strategies for the immunotherapy of glioblastoma;Biomaterials;2024-12

3. Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application;Coordination Chemistry Reviews;2024-11

4. UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1;International Journal of Biological Macromolecules;2024-10

5. ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway;Journal of Nanobiotechnology;2024-09-12